See more : Latteno Food Corp. (LATF) Income Statement Analysis – Financial Results
Complete financial analysis of HeartBeam, Inc. (BEAT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HeartBeam, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- Emirates Integrated Telecommunications Company PJSC (DU.AE) Income Statement Analysis – Financial Results
- Cypherpunk Holdings Inc. (HODL.CN) Income Statement Analysis – Financial Results
- GTN Limited (GTN.AX) Income Statement Analysis – Financial Results
- Playmaker Capital Inc. (PMKR.V) Income Statement Analysis – Financial Results
- EC Healthcare (UNHLF) Income Statement Analysis – Financial Results
HeartBeam, Inc. (BEAT)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.heartbeam.com
About HeartBeam, Inc.
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 399.47M | 286.78M | 208.33M | 178.51M | 166.58M | 129.50M | 111.49M | 119.02M | 119.92M | 140.62M | 120.45M | 72.99M | 33.92M | 30.94M | 22.23M | 7.92M |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 148.99M | 114.41M | 78.88M | 71.96M | 73.11M | 50.43M | 45.59M | 49.08M | 47.49M | 48.69M | 39.91M | 25.53M | 12.70M | 0.00 | 16.97M | 5.66M |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 250.49M | 172.37M | 129.45M | 106.56M | 93.46M | 79.07M | 65.90M | 69.95M | 72.43M | 91.93M | 80.54M | 47.47M | 21.22M | 30.94M | 5.26M | 2.26M |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 62.70% | 60.11% | 62.14% | 59.69% | 56.11% | 61.06% | 59.11% | 58.77% | 60.40% | 65.38% | 66.86% | 65.03% | 62.56% | 100.00% | 23.66% | 28.51% |
| Research & Development | 6.80M | 5.68M | 255.00K | 133.00K | 41.00K | 11.21M | 11.10M | 8.36M | 7.11M | 7.40M | 7.34M | 4.66M | 5.70M | 4.90M | 5.81M | 4.00M | 3.78M | 3.63M | 0.00 | 2.41M | 4.44M |
| General & Administrative | 8.52M | 7.35M | 2.03M | 655.00K | 0.00 | 112.43M | 88.60M | 56.60M | 47.93M | 45.80M | 37.06M | 33.42M | 35.01M | 34.66M | 39.15M | 41.92M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 42.85M | 35.32M | 28.64M | 27.94M | 28.81M | 26.28M | 25.60M | 27.82M | 29.34M | 34.66M | 21.11M | 0.00 | 0.00 | 0.00 | 7.70M | 3.53M |
| SG&A | 8.52M | 7.35M | 2.03M | 655.00K | 253.00K | 155.28M | 123.92M | 85.23M | 75.87M | 74.61M | 63.34M | 59.03M | 62.83M | 64.00M | 73.81M | 63.03M | 0.00 | 0.00 | 0.00 | 7.70M | 3.53M |
| Other Expenses | 0.00 | 3.00K | 22.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.08M | 18.58M | 19.98M | -1.06M | 43.44M | 22.08M | 0.00 | 15.25M | 7.02M |
| Operating Expenses | 15.31M | 13.03M | 2.29M | 788.00K | 294.00K | 166.48M | 135.02M | 93.59M | 82.98M | 82.00M | 70.67M | 63.69M | 80.61M | 87.47M | 99.60M | 65.97M | 47.22M | 25.71M | 0.00 | 25.36M | 14.99M |
| Cost & Expenses | 15.31M | 13.03M | 2.29M | 788.00K | 294.00K | 315.47M | 249.43M | 172.47M | 154.94M | 155.12M | 121.11M | 109.28M | 129.69M | 134.96M | 148.29M | 105.88M | 72.75M | 38.41M | 0.00 | 42.33M | 20.65M |
| Interest Income | 675.00K | 66.00K | 2.17K | 280.00 | 242.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 66.00K | 2.17M | 280.00K | 242.00K | 9.43M | 4.90M | 0.00 | 0.00 | 0.00 | 0.00 | 299.00K | 0.00 | 3.00K | 12.00K | 170.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 15.31M | 13.03M | 2.29M | 788.00K | 294.00K | 40.17M | 28.56M | 14.27M | 12.49M | 12.55M | 12.32M | 9.38M | 12.13M | 12.07M | 10.94M | 8.69M | 4.55M | 2.66M | -42.40M | -848.00K | 46.00K |
| EBITDA | 675.00K | -13.03M | 0.00 | -788.00K | -294.00K | 92.05M | 24.25M | 30.04M | 20.38M | 444.00K | 5.21M | -3.43M | -49.05M | -7.52M | -9.52M | 19.55M | 4.19M | -4.99M | -11.46M | -20.95M | -12.68M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 23.04% | 8.46% | 14.42% | 11.42% | 0.27% | 4.03% | -3.08% | -41.21% | -6.27% | -6.77% | 16.23% | 5.74% | -14.71% | -37.05% | -94.22% | -160.04% |
| Operating Income | -15.31M | -13.03M | -2.29M | -788.00K | -294.00K | 84.00M | 37.35M | 35.86M | 23.58M | 11.46M | 8.40M | 2.21M | -10.66M | -15.04M | -7.67M | 14.57M | 241.61K | -4.49M | 30.94M | -20.10M | -12.73M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 21.03% | 13.02% | 17.21% | 13.21% | 6.88% | 6.48% | 1.98% | -8.96% | -12.54% | -5.45% | 12.10% | 0.33% | -13.23% | 100.00% | -90.41% | -160.62% |
| Total Other Income/Expenses | 675.00K | 69.00K | -2.14M | -280.00K | -242.00K | -42.50M | -47.75M | -20.09M | -15.68M | -23.57M | -15.50M | -15.32M | -50.51M | -4.56M | -12.80M | -3.88M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -14.64M | -12.96M | -4.43M | -1.07M | -536.00K | 41.50M | -10.40M | 15.77M | 7.90M | -12.11M | -7.10M | -13.11M | -61.18M | -19.60M | -20.47M | 10.69M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 10.39% | -3.63% | 7.57% | 4.42% | -7.27% | -5.49% | -11.76% | -51.40% | -16.34% | -14.56% | 8.87% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -135.00K | 2.17M | 280.00K | 242.00K | -370.00K | 6.75M | -37.67M | 468.00K | -2.31M | 215.00K | -905.00K | 244.00K | 262.00K | 5.00K | 1.48M | 0.00 | 0.00 | 42.40M | 848.00K | -46.00K |
| Net Income | -14.64M | -12.83M | -6.59M | -1.35M | -778.00K | 42.82M | -15.96M | 53.44M | 7.43M | -9.79M | -7.32M | -12.20M | -61.42M | -19.86M | -20.48M | 9.21M | -358.07K | -7.64M | -11.46M | -20.95M | -12.68M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 10.72% | -5.56% | 25.65% | 4.16% | -5.88% | -5.65% | -10.94% | -51.61% | -16.56% | -14.56% | 7.64% | -0.49% | -22.54% | -37.05% | -94.22% | -160.04% |
| EPS | -0.72 | -1.57 | -0.84 | -0.17 | -0.10 | 1.20 | -0.53 | 1.91 | 0.27 | -0.37 | -0.29 | -0.49 | -2.51 | -0.82 | -0.86 | 0.50 | -0.12 | -2.63 | -4.04 | -7.33 | -5.23 |
| EPS Diluted | -0.72 | -1.57 | -0.84 | -0.17 | -0.10 | 1.20 | -0.53 | 1.75 | 0.26 | -0.37 | -0.29 | -0.49 | -2.51 | -0.82 | -0.86 | 0.41 | -0.12 | -2.63 | -4.04 | -7.33 | -5.23 |
| Weighted Avg Shares Out | 20.33M | 8.17M | 7.81M | 8.17M | 8.17M | 35.78M | 30.39M | 27.92M | 27.12M | 26.45M | 25.54M | 24.93M | 24.43M | 24.11M | 23.77M | 18.35M | 2.91M | 2.91M | 2.84M | 2.86M | 2.42M |
| Weighted Avg Shares Out (Dil) | 20.33M | 8.17M | 7.81M | 8.17M | 8.17M | 35.78M | 30.39M | 30.49M | 29.09M | 26.45M | 25.54M | 24.93M | 24.43M | 24.11M | 23.77M | 22.66M | 2.91M | 2.91M | 2.84M | 2.86M | 2.42M |
HeartBeam, Inc. (BEAT) Q3 2022 Earnings Call Transcript
HeartBeam, Inc. (NASDAQ:BEAT ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Branislav Vajdic – Founder and Chief Executive Officer Jon Hunt – Chief Business Officer Rick Brounstein – Chief Financial Officer Conference Call Participants...
These Were the Five Best and Worst Performing Healthcare Stocks in Q3 2022
The healthcare industry is now starting to shift its focus away from the coronavirus pandemic to work on its core activities.
These Were The Five Best And Worst Performing Healthcare Stocks In September 2022
September was another lackluster month for the stock market, with the S&P 500 dropping by over 9%.
HeartBeam to Present at LD Micro Main Event XV Conference
SANTA CLARA, Calif.
Why Is HeartBeam (BEAT) Stock Up 24% Today?
Source: shutterstock.com/Anastasia Zagoruyko HeartBeam (NASDAQ: BEAT ) stock is seeing gains on Thursday as investors react to news of it expanding its product portfolio pipeline. That expansion has the company working to develop arrhythmia detection capabilities.
HeartBeam to Present at Upcoming Investor Conferences
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Present at Upcoming Investor Conferences
Penny Stocks To Buy Now: 3 To Watch Under $3
Penny stocks to buy for under $3 The post Penny Stocks To Buy Now: 3 To Watch Under $3 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Buying Penny Stocks Today? What You Need to Know
Here's what you need to know about trading penny stocks on September 16th The post Buying Penny Stocks Today? What You Need to Know appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
What Is Going on With HeartBeam (BEAT) Stock Today?
Source: shutterstock.com/Anastasia Zagoruyko HeartBeam (NASDAQ: BEAT ) stock is rocketing higher on Thursday as investors react to news of a new heart monitor patent. This new patent covers a 12-lead electrocardiogram patch that's designed to monitor for acute coronary syndrome,...
Source: https://incomestatements.info
Category: Stock Reports